A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N-Nitroso-Lacidipine - Request Quote

Picture of N-Nitroso-Lacidipine

N-Nitroso-Lacidipine

SZ CAT No:SZ-L068003
CAS No
NA
Mol.F.
C26H32N2O7
Mol.Wt.
484.5
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

N-Nitroso-Lacidipine is chemically Diethyl (E)-4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate. N-Nitroso-Lacidipine is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso-Lacidipine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lacidipine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality N-Nitroso-Lacidipine

Purchase N-Nitroso-Lacidipine

N-Nitroso-Lacidipine suppliers

N-Nitroso-Lacidipine manufacturers

N-Nitroso-Lacidipine price

Order N-Nitroso-Lacidipine

Enquire N-Nitroso-Lacidipine

N-Nitroso-Lacidipine cost

N-Nitroso-Lacidipine Supplier

N-Nitroso-Lacidipine Distributor

N-Nitroso-Lacidipine for Method Validation

Lacidipine Reference Standard

N-Nitroso-Lacidipine for ANDA Filing

N-Nitroso-Lacidipine for Forced Degradation Studies

N-Nitroso-Lacidipine Identification Standards

N-Nitroso-Lacidipine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,